←Back to Expert Scholars
Translational Medicine / 转化医学Bispecific Antibodies, Lymphoma
Franck Morschhauser
MD, PhD
🏢Centre Hospitalier Universitaire de Lille🌐France
Professor of Hematology
75
h-index
0
Key Papers
0
Key Contributions
👥Biography 个人简介
Franck Morschhauser leads lymphoma trials through the French LYSA group at Lille and has contributed to pivotal mosunetuzumab and lenalidomide-rituximab trials in follicular lymphoma. He has led European studies of bispecific antibody combinations. His work informs European lymphoma guidelines.
Share:
🧪Research Fields 研究领域
follicular lymphoma
mosunetuzumab
lenalidomide rituximab
French LYSA
bispecific antibodies
🎓Key Contributions 主要贡献
Representative Works 代表性著作
📄Data Sources 数据来源
Last updated: 2026-04-01 | All information from publicly available academic sources
Related Experts 相关专家
Antoni Ribas
UCLA Jonsson Comprehensive Cancer Center
Melanoma ImmunotherapyCheckpoint Inhibitors
Drew M. Pardoll
Johns Hopkins University
Cancer ImmunologyPD-1/PD-L1 Pathway
Padmanee Sharma
MD Anderson Cancer Center
Bladder Cancer ImmunotherapyImmune Profiling
Naiyer A. Rizvi
Columbia University Irving Medical Center
Lung Cancer ImmunotherapyTumor Mutational Burden
关注 Franck Morschhauser 的研究动态
Follow Franck Morschhauser's research updates
留下邮箱，当我们发布与 Franck Morschhauser（Centre Hospitalier Universitaire de Lille）相关的新研究或访谈时，我们会通知你。
Explore More Experts
Discover the researchers shaping the future of cancer treatment